NATH BIO-GENES (INDIA) LTD.
Quaterly Results
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
---|---|---|---|---|
Audited / UnAudited | UnAudited | Audited | UnAudited | UnAudited |
Net Sales | 317.38 | 225.68 | 2352.81 | 449.88 |
Total Expenditure | 260.92 | 170.53 | 1984.73 | 410.53 |
PBIDT (Excl OI) | 56.46 | 55.15 | 368.08 | 39.35 |
Other Income | 0.37 | 0.62 | 1.17 | 2.56 |
Operating Profit | 56.83 | 55.77 | 369.25 | 41.91 |
Interest | 28.37 | 24.36 | 27.64 | 15.32 |
Exceptional Items | 25 | NA | NA | NA |
PBDT | 53.46 | 31.41 | 341.61 | 26.59 |
Depreciation | 7.6 | 7.6 | 7.6 | 9.9 |
Profit Before Tax | 45.86 | 23.81 | 334.01 | 16.69 |
Tax | 7.67 | 3.45 | 2.2 | 2.31 |
Provisions and contingencies | NA | NA | NA | NA |
Profit After Tax | 38.19 | 20.36 | 331.81 | 14.38 |
Extraordinary Items | NA | NA | NA | NA |
Prior Period Expenses | NA | NA | NA | NA |
Other Adjustments | NA | NA | NA | NA |
Net Profit | 38.19 | 20.36 | 331.81 | 14.38 |
Minority Interest | NA | NA | 0.22 | NA |
Shares of Associates | ||||
Other related items | ||||
Misc. Expenses Written off | NA | NA | NA | NA |
Consolidated Net Profit | 38.19 | 20.34 | 332.03 | 14.37 |
Equity Capital | 190.04 | 190.04 | 190.04 | 190.04 |
Face Value (IN RS) | 10 | 10 | 10 | 10 |
Reserves | 5889.3 | 5850.82 | 5873.72 | 5619.48 |
Calculated EPS | 2.00 | 1.07 | 17.47 | 0.75 |
Calculated EPS (Annualised) | 8.03 | 4.28 | 69.88 | 3.02 |
No of Public Share Holdings | 10339098 | 10339098 | 10339098 | 10339098 |
% of Public Share Holdings | 54.4 | 54.4 | 54.4 | 54.4 |
| NA | NA | NA | NA |
PBIDTM% (Excl OI) | 17.78 | 24.43 | 15.64 | 8.74 |
PBIDTM% | 17.90 | 24.71 | 15.69 | 9.31 |
PBDTM% | 16.84 | 13.91 | 14.51 | 5.91 |
PBTM% | 14.44 | 10.55 | 14.19 | 3.70 |
PATM% | 12.03 | 9.02 | 14.10 | 3.19 |
"; | Notes | Notes | Notes | Notes |